Presented By Rare Cannabinoid Company February 26, 2021
“… A recent study (May 2020) was conducted to compare the neuroprotective effects of CBD and CBG. The study’s authors said that “CBD’s effectiveness against neurological diseases has already been demonstrated,” so rodent experiments were carried out to quantify the differences between the two cannabinoids’ effects.
The scientists conducted multiple tests to mimic the effects of neurological diseases on rat tissue. Both CBD and CBG proved effective, but, when brain and spinal cord cells were exposed to hydrogen peroxide-induced toxicity, “CBG was more potent than CBD in blunting neurotransmitter depletion,” the study concluded. CBG was also more potent than CBD in counteracting toxicity in experiments done on rat cortexes.
Here are more links to specific studies on CBG and neurodegeneration:
For Parkinson’s disease, a 2018 study on mice found that CBG offers neuroprotection against damage caused by inflammation.
Also in 2018, a study was carried out on CBG’s effect on neuroinflammation(which is defined as an inflammatory response within the brain or spinal cord). This in vitro study found CBG to be effective at reducing neuronal death, inflammation, and oxidative stress. “In particular, CBG restored cell anti-oxidant defense.”